Acadian Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Acadian Asset Management's TNDM Position: Q2 2026 in Review
Acadian Asset Management reduced its Tandem Diabetes Care (TNDM) stake by 51% in Q2 2026, selling an estimated $2.46M and leaving 137,237 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1069.
Acadian Asset Management first reported a position in TNDM in Q4 2018 and has held it in 16 quarters since. The position peaked at $11.1M in Q3 2025. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Acadian Asset Management held 137,237 shares of Tandem Diabetes Care worth $2.06M as of Q2 2026.
- Acadian Asset Management sold 140,879 Tandem Diabetes Care shares in Q2 2026, an estimated $2.46M.
- Tandem Diabetes Care made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1069 holding.
- Acadian Asset Management first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 16 quarters since.
- Acadian Asset Management's Tandem Diabetes Care position peaked at $11.1M in Q3 2025.
- 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.